These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 20985568)

  • 1. Biologic changes in sulfonamide-resistant Mycobacterium ranae.
    YEGIAN D; BUDD V; MIDDLEBROOK G
    J Bacteriol; 1946 Apr; 51():479-85. PubMed ID: 20985568
    [No Abstract]   [Full Text] [Related]  

  • 2. The biological characteristics of streptomycin-dependent Mycobacterium ranae.
    FEGIAN D; VANDERLINDE RJ
    J Bacteriol; 1949 Feb; 57(2):169-78. PubMed ID: 18113425
    [No Abstract]   [Full Text] [Related]  

  • 3. A Variant of Mycobacterium ranae Requiring Streptomycin for Growth.
    Yegian D; Budd V
    J Bacteriol; 1948 Apr; 55(4):459-61. PubMed ID: 16561478
    [No Abstract]   [Full Text] [Related]  

  • 4. Mutation of streptomycin-dependent Mycobacterium ranae selected from a sulfathiazole-resistant variant.
    YEGIAN D; BUDD V
    J Bacteriol; 1951 Feb; 61(2):167-70. PubMed ID: 14824094
    [No Abstract]   [Full Text] [Related]  

  • 5. Genetic studies on the development of resistance to neomycin and dihydrostreptomycin in Mycobacterium ranae.
    HSIE JW; BRYSON V
    Trans Annu Meet Natl Tuberc Assoc; 1950; 46():97-115. PubMed ID: 14788197
    [No Abstract]   [Full Text] [Related]  

  • 6. Sulfonamide activity against Mycobacterium fortuitum and Mycobacterium chelonei.
    Wallace RJ; Jones DB; Wiss K
    Rev Infect Dis; 1981; 3(5):898-904. PubMed ID: 7339821
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Acetyl L-isoleucine and acetyl L-leucine as extracellular products of Mycobacterium ranae.
    FOWLER AV; CAMIEN MN; DUNN MS
    J Bacteriol; 1961 Jan; 81(1):163-4. PubMed ID: 13701061
    [No Abstract]   [Full Text] [Related]  

  • 8. Genetic studies on microbial cross-resistance to toxic agents. III. Cross-resistance of Mycobacterium ranae to twenty-eight antimycobacterial agents.
    SZYBALSKI W; BRYSON V
    Am Rev Tuberc; 1954 Feb; 69(2):267-79. PubMed ID: 13114644
    [No Abstract]   [Full Text] [Related]  

  • 9. Isoniazid-dependent strains of Mycobacterium ranae.
    BRYSON V; DEICHES H; SZYBAISKI W
    Am Rev Tuberc; 1953 Oct; 68(4):631-3. PubMed ID: 13104878
    [No Abstract]   [Full Text] [Related]  

  • 10. [Changes in the kidneys in patients with successive findings of Mycobacterium xenopi and Mycobacterium fortuitum in the urine--report of 16 cases]].
    Lovodić-Sivcev B; Vukelić A
    Med Pregl; 1999; 52(9-10):334-42. PubMed ID: 10624381
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Extracellular acids produced by Mycobacterium ranae and Mycobacterium tuberculosis H37Rv.
    FOWLER AV; CAMIEN MN; DUNN MS
    J Biol Chem; 1960 May; 235():1386-9. PubMed ID: 13824211
    [No Abstract]   [Full Text] [Related]  

  • 12. [Lipasic activity of Mycobacterium ranae].
    CATTANEO G
    Arch Sci Med (Torino); 1955 Jul; 100(1):34-43. PubMed ID: 13259930
    [No Abstract]   [Full Text] [Related]  

  • 13. STUDIES ON THE BIURET-HYDROLYZING ENZYME FROM MYCOBACTERIUM RANAE.
    NISHIHARA H; SHOJI K; HORI M
    Biken J; 1965 Apr; 8():23-34. PubMed ID: 14340035
    [No Abstract]   [Full Text] [Related]  

  • 14. BOUND INTRACELLULAR GLYCOLIC AND D-LACTIC ACIDS IN MYCOBACTERIUM RANAE.
    FOWLER AV; CAMIEN MN; DUNN MS
    J Bacteriol; 1964 Jun; 87(6):1528-9. PubMed ID: 14188739
    [No Abstract]   [Full Text] [Related]  

  • 15. Studies on the toxic substances isolated from mycobacteria. I. Toxic glycolipids of Mycobacteria fortuitum and mycobacteria strain P16.
    AZUMA I; YAMAMURA Y
    J Chromatogr; 1962 Aug; 8():82-91. PubMed ID: 13863585
    [No Abstract]   [Full Text] [Related]  

  • 16. Multiple lumps in the breast due to Mycobacterium fortuitum.
    Chandanwale SS; Gulati I; Baravkar DS; Shinde SP; Mishra N
    Indian J Tuberc; 2016 Apr; 63(2):126-9. PubMed ID: 27451824
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [On the presence of acylamidases in mycobacteria. Part IV. The differentiation of rapidly growing mycobacteria of the species Mycobacterium smegmatis. Mycobacterium phlei. Mycobacterium fortuitum and Mycobacterium thamnopheos by demonstration of their different acylamidase metabolism ability].
    BOENICKE R
    Zentralbl Bakteriol; 1960 Jun; 179():209-30. PubMed ID: 13849090
    [No Abstract]   [Full Text] [Related]  

  • 18. Successful bedaquiline-containing antimycobacterial treatment in post-traumatic skin and soft-tissue infection by Mycobacterium fortuitum complex: a case report.
    Erber J; Weidlich S; Tschaikowsky T; Rothe K; Schmid RM; Schneider J; Spinner CD
    BMC Infect Dis; 2020 May; 20(1):365. PubMed ID: 32448204
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Species Distribution and Macrolide Susceptibility of
    Kim SY; Moon SM; Jhun BW; Kwon OJ; Huh HJ; Lee NY; Lee SH; Shin SJ; Kasperbauer SH; Huitt GA; Daley CL; Koh WJ
    Antimicrob Agents Chemother; 2019 Jun; 63(6):. PubMed ID: 30885902
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of antimicrobial activity among new sulfonamide metal complexes for combating rapidly growing mycobacteria.
    Agertt VA; Bonez PC; Rossi GG; Flores Vda C; Siqueira Fdos S; Mizdal CR; Marques LL; de Oliveira GN; de Campos MM
    Biometals; 2016 Oct; 29(5):807-16. PubMed ID: 27567903
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.